Product: Neostigmine Methylsulfate Injection in all strengths, all doses, and all packaging.
Reason for recall: Lack of sterility assurance.
Recall initiated: 20171227
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated